2nd Decoding Digital Health

ON-DEMAND CONTENT | VIRTUAL EVENT

PURCHASE ON-DEMAND
Download Brochure

AGENDA – ALL TIMES ARE IN EASTERN TIME

Paul Ivans
Founder & CEO
EVOLUTION ROAD
Todd Kolm
Chief Innovation Officer
EVOLUTION ROAD

Kate Miller
Chief Strategy Officer
EVOLUTION ROAD
Moderator:
Todd Kolm
Chief Innovation Officer
EVOLUTION ROAD

Interviewee:
Meghan Rivera
Managing Director, US
ORGANON
  • Hear how Ironwood identified and solved for true customer needs and married them with business objectives
  • Understand firsthand how company leadership overcame countless barriers to develop a novel approach to telemedicine
  • Understand firsthand how company leadership overcame countless barriers to develop a novel approach to telemedicine
Moderator:
Kate Miller
Chief Strategy Officer
EVOLUTION ROAD

Interviewee:
Thomas McCourt
Chief Executive Officer
IRONWOOD PHARMACEUTICALS
In the last few years, most Venture Capital (VC) firms have started to look at at the entire healthcare industry — including biopharma — as a big opportunity for transformation and disruption. However, most biopharma companies tend to focus on near term, Horizon 1 type investments (12-18mth) based on their annual planning cycle, whereas VCs tend to look at the longer Horizon 2 and 3 opportunities for disruption. This fireside chat / panel will therefore discuss:

  • Trends and opportunities for digital health disruption in pharma (across the lifecycle)
  • Examining the VC perspective on investments related to the pharma industry
  • Lessons from former pharma executives who are now in VC
  • How to partner with VCs to help guide biopharma innovation
Moderator:
Shwen Gwee
Vice President and Head of Global Digital Strategy
BRISTOL MYERS SQUIBB

Interviewee:
Jessica Federer
Partner
BOSTON MILLENNIA PARTNERS
  • What are the challenges of executing digital health/ innovation in pharma?
  • How do you overcome those challenges?
  • How do you measure value / success?
  • How do you create a business case to drive continued investment?
Moderator:
Bernice Ma
Associate Principal, Digital Health Practice
EVOLUTION ROAD

Panelists:

Dhiren Patel, Pharm
Senior Vice President of Commercial
PACK HEALTH, A QUEST DIAGNOSTICS COMPANY

Brett Wisse, PMP
Director of Client Services
PACK HEALTH, A QUEST DIAGNOSTICS COMPANY

Jaimin Mahedevia
Group Product Director Neuroscience Franchise Marketing MS,
THE JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON

Michelle Chung
Product Director, Professional Promotion, Multiple Sclerosis
THE JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON
  • Developing experiences that over deliver on expectations and maximize ROI helps ensure that you’re getting the most value out of your patient access investments.
  • One-size-fits-all digital strategies don’t really fit all. Meet your customers where they are by identifying them at the point of care.
  • Creating an accurate map of your customer journey across the product life cycle requires expanding on existing insights and identifying potential blind spots.
  • Small changes can make a big difference. Incremental innovation helps drive results by delighting customers, which leads to increased engagement.
Akeel Williams
Vice President of Strategy, Business Development and Operations
GOODRX
Our world has changed dramatically in the last two years as unmet needs, especially in mental health, have reached crisis levels. Solving for crises requires we go beyond simply aiming for incremental improvements. We must learn how to rapidly and deliberately apply innovation to make more significant and impactful progress. Join this panel of experts from some of the most innovative pharma companies and health systems for a rich discussion about how to make innovation work in a dynamic world. We’ll explore:

  • What is innovation in 2022? Is it a project, a mindset, a culture?
  • What's the phenotype of an innovation leader and team today?
  • How much does mindset and psychology play a role?
  • Where are we in the pendulum of siloed vs. integrated innovation efforts?
  • What are practical ways to create a culture of innovation?
Moderator:
Monique Levy
Chief Commercial and Strategy Officer
WOEBOT HEALTH

Panelists:
Sophie Park
Managing Director - G4A Investments and Partnerships
BAYER

Tarun Kapoor
Senior Vice President and Chief Digital Transformation Officer
VIRTUA HEALTH
Sukhveer Singh
Global Head of Healthcare Insights, Roche Informatics Solutions
ROCHE
  • Discussing the current landscape: start up partners vs. established tech companies
  • Should pharma be worried about tech companies taking market share in digital health opportunities?
  • Data sharing, due diligence and trust
Moderator:
Melissa Saw
Director, Marketing Procurement
BAYER

Panelists:

Jason O’Meara
Vice President, Enterprise Data and Solutions Architecture
PFIZER

Joy Bhosai
Co-Founder and CEO
PLUTO HEALTH

John Thomas
Formerly Principal, Healthcare Strategy and Solutions
AMAZON BUSINESS
  • The top unique challenges and barriers for pharma – internal view
  • The top unique challenges and barriers for pharma – external view
  • Tips to overcome some of the challenges
  • The opportunity of improving outcomes to our patients together with the drug
  • Data strategy and integration
Amir Zur
Head of R&D Digital Health Products
TAKEDA PHARMACEUTICALS
Moderator:
Alvaro Luna
Associate Principal
EVOLUTION ROAD

Interviewee:
Greg Eater
Director, Digital Health and Innovative Alliances, US Markets
MERCK
Priya Durvasula
Associate Vice President, Digital Quality
ELI LILLY
  • Understanding what your patients care about
  • Understanding what impacts your patients the most
  • Integrating patient generated and real-world data with brand plans
  • Understanding how digital health can empower your therapy as well as improve the lives of patients
  • Avoiding common mistakes in adopting digital health
Sarah Ernst
Senior Director, Digital Strategy and Marketing
SANOFI
  • Digital Health Landscape: Players/Roles (pharma, payer, healthcare systems/providers, technology innovators)
  • Problems to solve:
    ○ Unlocking longitudinal datasets
    ○ Driving clinical outcomes by bridging the gap between patient and provider
    ○ Shortening the gap between generating clinical evidence and changing clinical practice
    ○ Improving clinical trial patient recruitment timelines and diversity, etc.
  • How pharma provides solutions to drive innovation
  • Building a sustainable foundation
Abby Staible
Director, Global Commercial Digital and Innovation
ASTRAZENECA
  • Digital biomarkers (dBMs)
  • Behavioral coaching
  • Digital therapies
Jian Yang
Senior Director, Digital Health
ELI LILLY  
  • Frumpy: The anatomy of the monolithic SaMD product
  • The SaMD mashup: modularity and interoperability as strategic tools
  • Achieving immortality: smart scaling of products and labels
Brad van Orden
Director Digital Medicine and Digital Therapeutics
BRISTOL MYERS SQUIBB
In this fireside chat, Evolution Road and HealthXL will share data highlighting some of key challenges faced by pharma collectively as it relates to executing digital health and discuss potential solutions based on their collective experience supporting life science in digital health innovation:

  • What are some of the common challenges that life science face when it comes to executing digital health?
  • How have the most innovative pharma companies overcome some of these challenges?
  • What makes some pharma companies more successful than others? What are some of the best practices that we have seen that increases pharma’s chance of success?
Moderator:
Bernice Ma
Associate Principal, Digital Health Practice
EVOLUTION ROAD

Interviewee:
Chandana Fitzgerald
General Manager and Chief Marketing Officer
HEALTHXL
Investments in digital health startups continue to rise at an unprecedented rate and, consequently, the number of partnerships between biopharma and digital health companies also continue to grow. There are a number of different vehicles by which a (biopharma) corporation can partner with them, including: Strategic/Financial Investments, Co-Development and Commercialization, Incubation and Acceleration and Acquisition. This panel will discuss the best practices for partnering with Digital Health companies (especially startups) and how to optimize the value beyond a "standard" procurement process.

  • Preparing to partner — best practices for optimizing the sourcing for the right digital health company
  • Who should lead the search — BD, procurement, innovation teams or agencies?
  • Best practices for onboarding and aligning startups with big corporate/pharma practices, pace and culture
  • Identifying win-win opportunities / areas for all parties
Moderator:
Shwen Gwee
Vice President and Head of Global Digital Strategy
BRISTOL MYERS SQUIBB

Interviewee:
Jake Laporte
Co-Founder and Vice President, Global Head of Biome, The Digital Innovation Lab
NOVARTIS
Ensuring digital health is solving for real patient/care-giver and HCP unmet needs; how to avoid undertaking digital health for digital health’s sake

  • Importance of having clear goals/objectives from the start (e.g. improving access for certain patient populations who have historically been underserved)
  • Incorporate human-centered design concepts and best practices
  • Ensuring health equity considerations are woven into the development process
  • How can SDoH help ensure we aren’t developing digital health solutions that merely serve the digitally-enabled
Moderator:
Mischa Cohn
Senior Consultant
EVOLUTION ROAD

Panelists:
Pamela Abaza R.Ph., M.S.M.
Director Human Health IT, Patient Access, Public Policy and Affordability
MERCK

Whit Rawlinson
US Oncology Marketing, Digital Innovation and Customer Experience
MERCK ONCOLOGY

Mike Hartwell
Strategic Sales Director, Life Sciences
UNITE US